Index Entries

Approved on April 30, 2021
Pfizer, Inc.

This document was produced by the Food and Drug Administration (FDA) in response to a Freedom of Information Act (FOIA) request (see https://phmpt.org/wp-content/uploads/2021/10/001-Complaint-101021.pdf). The request was submitted by Public Health and Medical Professionals for Transparency

Appendix 1 (pp. 30-38) lists more than 1,200 "adverse events of special interest" identified in the report period (ending February 28, 2021).

document
adverse events,clinical trials,COVID-19,manufacturers,vaccines